Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Neoplasms of the CNS

  Free Subscription


20.05.2019

1 Acta Neuropathol
1 AJNR Am J Neuroradiol
2 BMC Cancer
1 Cancer Res
1 Eur J Cancer
1 Int J Cancer
3 Int J Radiat Oncol Biol Phys
1 J Neurooncol
2 J Neurosurg
5 Neuro Oncol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. SHARMA T, Schwalbe EC, Williamson D, Sill M, et al
    Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
    Acta Neuropathol. 2019 May 10. pii: 10.1007/s00401-019-02020.
    PubMed     Text format     Abstract available


    AJNR Am J Neuroradiol

  2. WANG YL, Yao J, Chakhoyan A, Raymond C, et al
    Association between Tumor Acidity and Hypervascularity in Human Gliomas Using pH-Weighted Amine Chemical Exchange Saturation Transfer Echo-Planar Imaging and Dynamic Susceptibility Contrast Perfusion MRI at 3T.
    AJNR Am J Neuroradiol. 2019 May 16. pii: ajnr.A6063. doi: 10.3174/ajnr.A6063.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. CUNCANNON M, Wong M, Jayamanne D, Guo L, et al
    Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.
    BMC Cancer. 2019;19:445.
    PubMed     Text format     Abstract available

  4. ZHONG C, Shu M, Ye J, Wang X, et al
    Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma.
    BMC Cancer. 2019;19:441.
    PubMed     Text format     Abstract available


    Cancer Res

  5. TODOROVA PK, Fletcher-Sananikone E, Mukherjee B, Kollipara R, et al
    Radiation-induced DNA damage cooperates with heterozygosity of TP53 and PTEN to generate high grade gliomas.
    Cancer Res. 2019 May 14. pii: 0008-5472.CAN-19-0680.
    PubMed     Text format     Abstract available


    Eur J Cancer

  6. SMITS M, Bendszus M, Collette S, Postma LA, et al
    Repeatability and reproducibility of relative cerebral blood volume measurement of recurrent glioma in a multicentre trial setting.
    Eur J Cancer. 2019;114:89-96.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. VARON M, Levy T, Mazor G, Ben David H, et al
    The long non-coding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells.
    Int J Cancer. 2019 May 13. doi: 10.1002/ijc.32400.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  8. SOLTYS SG, Laack NN, Halasz LM, Minniti G, et al
    Treatment of WHO Grade 2 and 3 Gliomas With Potentially Favorable Survival: Is Monotherapy Obsolete?
    Int J Radiat Oncol Biol Phys. 2019;103:533-536.
    PubMed     Text format    

  9. PINNIX CC, Yahalom J, Specht L, Dabaja BS, et al
    Radiation in Central Nervous System Leukemia: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;102:53-58.
    PubMed     Text format    

  10. BOVI JA, Schultz CJ, Mehta MP, Corn BW, et al
    Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order.
    Int J Radiat Oncol Biol Phys. 2018;102:59-60.
    PubMed     Text format    


    J Neurooncol

  11. HU T, Wang R, Wang H, Song Y, et al
    Comparative analysis of intracranial meningiomas in patients younger than 40 years.
    J Neurooncol. 2019 May 13. pii: 10.1007/s11060-019-03191.
    PubMed     Text format     Abstract available


    J Neurosurg

  12. MOTOMURA K, Chalise L, Ohka F, Aoki K, et al
    Neurocognitive and functional outcomes in patients with diffuse frontal lower-grade gliomas undergoing intraoperative awake brain mapping.
    J Neurosurg. 2019 May 17:1-9. doi: 10.3171/2019.3.JNS19211.
    PubMed     Text format     Abstract available

  13. ROSSI M, Ambrogi F, Gay L, Gallucci M, et al
    Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome.
    J Neurosurg. 2019 May 17:1-14. doi: 10.3171/2019.2.JNS183408.
    PubMed     Text format     Abstract available


    Neuro Oncol

  14. PAPAIOANNOU MD, Djuric U, Kao J, Karimi S, et al
    Proteomic analysis of meningiomas reveals clinically-distinct molecular patterns.
    Neuro Oncol. 2019 May 11. pii: 5488088. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. GALLDIKS N, Unterrainer M, Judov N, Stoffels G, et al
    Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET - Clinical relevance in glioma patients.
    Neuro Oncol. 2019 May 11. pii: 5488073. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. JALALI R, Goda JS
    Proton beam therapy in pediatric brain tumor patients: Improved radiation delivery techniques improve neurocognitive outcomes.
    Neuro Oncol. 2019 May 13. pii: 5488773. doi: 10.1093.
    PubMed     Text format    

  17. TZARIDIS T, Gepfner-Tuma I, Hirsch S, Skardelly M, et al
    Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.
    Neuro Oncol. 2019 Apr 23. pii: 5476431. doi: 10.1093.
    PubMed     Text format    

  18. DARDAUD LM, Bris C, Desquiret-Dumas V, Boisselier B, et al
    High mitochondrial DNA copy number is associated with longer survival in young patients with glioblastoma.
    Neuro Oncol. 2019 Apr 26. pii: 5480712. doi: 10.1093.
    PubMed     Text format    


    PLoS One

  19. INADA M, Shindo M, Kobayashi K, Sato A, et al
    Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells.
    PLoS One. 2019;14:e0216358.
    PubMed     Text format     Abstract available

  20. SCHULTEN HJ, Hussein D
    Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
    PLoS One. 2019;14:e0215452.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: